• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖与新冠肺炎呼吸衰竭危重症患者的死亡率。

Obesity and mortality in critically ill COVID-19 patients with respiratory failure.

机构信息

Department of Anesthesiology and Intensive Care Medicine, CHRU-Nancy, Université de Lorraine, Nancy, France.

Medical Information Department, CHRU-Nancy, CNRS, Inria, LORIA, Université de Lorraine, Nancy, France.

出版信息

Int J Obes (Lond). 2021 Sep;45(9):2028-2037. doi: 10.1038/s41366-021-00872-9. Epub 2021 Jun 10.

DOI:10.1038/s41366-021-00872-9
PMID:34112941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8190754/
Abstract

BACKGROUND

Patients with obesity are at increased risk of severe COVID-19, requiring mechanical ventilation due to acute respiratory failure. However, conflicting data are obtained for intensive care unit (ICU) mortality.

OBJECTIVE

To analyze the relationship between obesity and in-hospital mortality of ICU patients with COVID-19.

SUBJECTS/METHODS: Patients admitted to the ICU for COVID-19 acute respiratory distress syndrome (ARDS) were included retrospectively. The following data were collected: comorbidities, body mass index (BMI), the severity of ARDS assessed with PaO/FiO (P/F) ratios, disease severity measured by the Simplified Acute Physiology Score II (SAPS II), management and outcomes.

RESULTS

For a total of 222 patients, there were 34 patients (15.3%) with normal BMI, 92 patients (41.4%) who were overweight, 80 patients (36%) with moderate obesity (BMI:30-39.9 kg/m), and 16 patients (7.2%) with severe obesity (BMI ≥ 40 kg/m). Overall in-hospital mortality was 20.3%. Patients with moderate obesity had a lower mortality rate (13.8%) than patients with normal weight, overweight or severe obesity (17.6%, 21.7%, and 50%, respectively; P = 0.011. Logistic regression showed that patients with a BMI ≤ 29 kg/m (odds ratio [OR] 3.64, 95% CI 1.38-9.60) and those with a BMI > 39 kg/m (OR 10.04, 95% CI 2.45-41.09) had a higher risk of mortality than those with a BMI from 29 to 39 kg/m. The number of comorbidities (≥2), SAPS II score, and P/F < 100 mmHg were also independent predictors for in-hospital mortality.

CONCLUSIONS

COVID-19 patients admitted to the ICU with moderate obesity had a lower risk of death than the other patients, suggesting a possible obesity paradox.

摘要

背景

肥胖患者患严重 COVID-19 的风险增加,需要因急性呼吸衰竭而进行机械通气。然而,关于重症监护病房(ICU)死亡率的结果却存在冲突。

目的

分析肥胖与 COVID-19 患者 ICU 住院死亡率之间的关系。

受试者/方法:回顾性纳入因 COVID-19 急性呼吸窘迫综合征(ARDS)而入住 ICU 的患者。收集以下数据:合并症、体重指数(BMI)、用 PaO/FiO(P/F)比值评估的 ARDS 严重程度、用简化急性生理学评分 II(SAPS II)测量的疾病严重程度、管理和结局。

结果

共有 222 例患者,其中 34 例(15.3%)BMI 正常,92 例(41.4%)超重,80 例(36%)中度肥胖(BMI:30-39.9kg/m),16 例(7.2%)重度肥胖(BMI≥40kg/m)。总体院内死亡率为 20.3%。中度肥胖患者的死亡率(13.8%)低于 BMI 正常、超重或重度肥胖患者(17.6%、21.7%和 50%,P=0.011)。Logistic 回归显示,BMI≤29kg/m(比值比 [OR] 3.64,95%CI 1.38-9.60)和 BMI>39kg/m(OR 10.04,95%CI 2.45-41.09)的患者死亡风险高于 BMI 为 29-39kg/m 的患者。合并症数量(≥2)、SAPS II 评分和 P/F<100mmHg 也是院内死亡率的独立预测因素。

结论

入住 ICU 的 COVID-19 肥胖患者的死亡风险低于其他患者,提示可能存在肥胖悖论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e386/8190754/448a3901f64c/41366_2021_872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e386/8190754/448a3901f64c/41366_2021_872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e386/8190754/448a3901f64c/41366_2021_872_Fig1_HTML.jpg

相似文献

1
Obesity and mortality in critically ill COVID-19 patients with respiratory failure.肥胖与新冠肺炎呼吸衰竭危重症患者的死亡率。
Int J Obes (Lond). 2021 Sep;45(9):2028-2037. doi: 10.1038/s41366-021-00872-9. Epub 2021 Jun 10.
2
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.4244 例危重症 COVID-19 成年患者的临床特征和第 90 天结局:一项前瞻性队列研究。
Intensive Care Med. 2021 Jan;47(1):60-73. doi: 10.1007/s00134-020-06294-x. Epub 2020 Oct 29.
3
Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the "obesity paradox" phenomenon.体重指数与急性低氧性呼吸衰竭的重症 COVID-19 患者的临床结局:揭开“肥胖悖论”现象。
Clin Nutr ESPEN. 2022 Oct;51:377-384. doi: 10.1016/j.clnesp.2022.07.016. Epub 2022 Aug 6.
4
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.阿根廷 COVID-19 有创通气患者的临床特征和结局(SATICOVID):一项前瞻性、多中心队列研究。
Lancet Respir Med. 2021 Sep;9(9):989-998. doi: 10.1016/S2213-2600(21)00229-0. Epub 2021 Jul 2.
5
Higher BMI is associated with reduced mortality but longer hospital stays following ICU discharge in critically ill Asian patients.在危重症亚洲患者中,较高的体重指数与死亡率降低相关,但在重症监护病房出院后的住院时间更长。
Clin Nutr ESPEN. 2018 Dec;28:165-170. doi: 10.1016/j.clnesp.2018.08.009. Epub 2018 Sep 27.
6
Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients.体重指数与 2019 冠状病毒病及其他疾病患者死亡率的关系:35506 例 ICU 患者的队列研究。
Crit Care Med. 2022 Jan 1;50(1):e1-e10. doi: 10.1097/CCM.0000000000005216.
7
Biomarkers as predictors of mortality in critically ill obese patients with COVID-19 at high altitude.高海拔地区危重症肥胖 COVID-19 患者的生物标志物对死亡率的预测作用。
BMC Pulm Med. 2023 Apr 6;23(1):112. doi: 10.1186/s12890-023-02399-3.
8
Relationship Between Body Mass Index and Survival Among Critically Ill Patients With Cirrhosis.肝硬化重症患者的体重指数与生存率的关系
J Intensive Care Med. 2022 Jun;37(6):817-824. doi: 10.1177/08850666211029827. Epub 2021 Jul 5.
9
BMI and mortality in critically ill patients with COVID-19: another brick in the wall of the obesity paradox.BMI 与 COVID-19 重症患者的死亡率:肥胖悖论之墙上又添一块砖。
Obesity (Silver Spring). 2024 Aug;32(8):1474-1482. doi: 10.1002/oby.24069. Epub 2024 Jun 30.
10
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.美国新冠肺炎住院患者中超重和肥胖相关的疾病负担:对2020年4月1日至2020年10月31日期间首要医疗保健数据库的分析
J Med Econ. 2023 Jan-Dec;26(1):376-385. doi: 10.1080/13696998.2023.2183679.

引用本文的文献

1
Pronounced effects of the sepsis-obesity paradox in elderly and male individuals without septic shock and the role of immune-inflammatory status: an analysis of MIMIC-IV data.脓毒症-肥胖悖论在无感染性休克的老年和男性个体中的显著影响及免疫炎症状态的作用:一项对多中心重症医学信息数据库-IV数据的分析
BMC Infect Dis. 2025 Apr 17;25(1):545. doi: 10.1186/s12879-025-10938-y.
2
Casual correlation between overweight, obesity, and severe COVID-19 infection with respiratory failure: A two-sample Mendelian randomization.超重、肥胖与伴有呼吸衰竭的重症新型冠状病毒肺炎感染之间的偶然关联:一项两样本孟德尔随机化研究
Medicine (Baltimore). 2025 Jan 3;104(1):e41006. doi: 10.1097/MD.0000000000041006.
3

本文引用的文献

1
Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases.SGLT2 抑制剂、GLP-1 受体激动剂、DPP-4 抑制剂和磺脲类药物在肾脏结局风险方面的比较效果:使用医疗保健数据库模拟目标试验。
Diabetes Care. 2020 Nov;43(11):2859-2869. doi: 10.2337/dc20-1890. Epub 2020 Sep 16.
2
Wildfires: Australia needs national monitoring agency.野火:澳大利亚需要国家监测机构。
Nature. 2020 Aug;584(7820):188-191. doi: 10.1038/d41586-020-02306-4.
3
Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.
AI-powered model for predicting mortality risk in VA-ECMO patients: a multicenter cohort study.
用于预测VA-ECMO患者死亡风险的人工智能模型:一项多中心队列研究。
Sci Rep. 2025 Mar 26;15(1):10362. doi: 10.1038/s41598-025-94734-3.
4
An interpretable machine learning model for predicting in-hospital mortality in ICU patients with ventilator-associated pneumonia.一种用于预测呼吸机相关性肺炎重症监护病房患者院内死亡率的可解释机器学习模型。
PLoS One. 2025 Jan 7;20(1):e0316526. doi: 10.1371/journal.pone.0316526. eCollection 2025.
5
Association of obesity and mortality in patients with COVID-19 acute respiratory distress syndrome: A retrospective cohort study.2019冠状病毒病急性呼吸窘迫综合征患者肥胖与死亡率的关联:一项回顾性队列研究。
Int J Crit Illn Inj Sci. 2024 Jul-Sep;14(3):153-159. doi: 10.4103/ijciis.ijciis_27_24. Epub 2024 Sep 20.
6
Predictive biomarkers of mortality in patients with severe COVID-19 hospitalized in intensive care unit.入住重症监护病房的重症新型冠状病毒肺炎患者死亡的预测生物标志物
Front Immunol. 2024 Aug 30;15:1416715. doi: 10.3389/fimmu.2024.1416715. eCollection 2024.
7
The obesity paradox and 90 day mortality in chronic critically ill patients: a cohort study using a large clinical database.肥胖悖论与慢性危重症患者 90 天死亡率:一项基于大型临床数据库的队列研究。
Eur J Med Res. 2024 Jul 29;29(1):392. doi: 10.1186/s40001-024-01962-w.
8
Influence of obesity on mortality, mechanical ventilation time and mobility of critical patients with COVID-19.肥胖对 COVID-19 危重症患者死亡率、机械通气时间和活动能力的影响。
Crit Care Sci. 2024 Jul 8;36:e20240253en. doi: 10.62675/2965-2774.20240253-en. eCollection 2024.
9
Is Steatotic Liver Disease Related to Poor Outcome in COVID-19-Hospitalized Patients?脂肪性肝病与COVID-19住院患者的不良预后有关吗?
J Clin Med. 2024 May 3;13(9):2687. doi: 10.3390/jcm13092687.
10
Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance.特发性肺动脉高压患者血清 PM20D1 水平及其临床意义。
BMC Cardiovasc Disord. 2024 Apr 13;24(1):207. doi: 10.1186/s12872-024-03855-6.
肥胖是 COVID-19 患者发展为危急病情的一个风险因素:系统评价和荟萃分析。
Obes Rev. 2020 Oct;21(10):e13095. doi: 10.1111/obr.13095. Epub 2020 Jul 19.